{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:16:20Z","timestamp":1770840980701,"version":"3.50.1"},"publisher-location":"Cham","reference-count":40,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319573786","type":"print"},{"value":"9783319573793","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-57379-3_6","type":"book-chapter","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T08:34:05Z","timestamp":1506674045000},"page":"55-65","source":"Crossref","is-referenced-by-count":9,"title":["Huntington Disease: Genetics, Prevention, and Therapy Approaches"],"prefix":"10.1007","author":[{"given":"Christos","family":"Yapijakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,30]]},"reference":[{"key":"6_CR1","first-page":"317","volume":"26","author":"G Huntington","year":"1872","unstructured":"Huntington, G. 1872. On Chorea. Medical Surgical Report 26: 317\u2013321.","journal-title":"Medical Surgical Report"},{"issue":"5","key":"6_CR2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/jmg.30.5.406","volume":"30","author":"N Durbach","year":"1993","unstructured":"Durbach, N., and M.R. Hayden. 1993. George Huntington: The Man Behind the Eponym. Journal of Medical Genetics 30 (5): 406\u2013409.","journal-title":"Journal of Medical Genetics"},{"issue":"4","key":"6_CR3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/jmg.3.4.298","volume":"3","author":"NC Myrianthopoulos","year":"1966","unstructured":"Myrianthopoulos, N.C. 1966. Huntington\u2019s Chorea. Journal of Medical Genetics 3 (4): 298\u2013314.","journal-title":"Journal of Medical Genetics"},{"key":"6_CR4","volume-title":"Mapping Fate: A Memoir of Family, Risk, and Genetic Research","author":"A Wexler","year":"1996","unstructured":"Wexler, A. 1996. Mapping Fate: A Memoir of Family, Risk, and Genetic Research. California: University of California Press."},{"key":"6_CR5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/306234a0","volume":"306","author":"JF Gusella","year":"1983","unstructured":"Gusella, J.F., N.S. Wexler, P.M. Conneally, S.L. Naylor, M.A. Anderson, R.E. Tanzi, P.C. Watkins, K. Ottina, M.R. Wallace, A.Y. Sakaguchi, et al. 1983. A Polymorphic DNA Marker Genetically Linked to Huntington\u2019s Disease. Nature 306: 234\u2013238.","journal-title":"Nature"},{"key":"6_CR6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1172\/JCI114222","volume":"84","author":"ME MacDonald","year":"1989","unstructured":"MacDonald, M.E., S.V. Cheng, M. Zimmer, J.L. Hains, A.M. Poustka, B.A. Allitto, B. Smith, et al. 1989. Clustering of Multiallele DNA Markers Near the Huntington\u2019s Disease Gene. The Journal of Clinical Investigation 84: 1013\u20131016.","journal-title":"The Journal of Clinical Investigation"},{"key":"6_CR7","first-page":"357","volume":"51","author":"RG Snell","year":"1992","unstructured":"Snell, R.G., L.M. Thompson, D.A. Tagle, T.L. Holloway, G. Barnes, H.G. Harley, L.A. Sandkuijl, et al. 1992. A Recombination Event That Redefines the Huntington Disease Region. American Journal of Human Genetics 51: 357\u2013362.","journal-title":"American Journal of Human Genetics"},{"key":"6_CR8","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/jmg.30.12.1020","volume":"30","author":"The World Federation of Neurology Research Group on Huntington\u2019s Disease","year":"1993","unstructured":"The World Federation of Neurology Research Group on Huntington\u2019s Disease. 1993. Presymptomatic Testing for Huntington\u2019s Disease: A World Wide Survey. Journal of Medical Genetics 30: 1020\u20131022.","journal-title":"Journal of Medical Genetics"},{"key":"6_CR9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group. 1993. A Novel Gene (HTT) Containing a Trinucleotide Repeat That Is Expanded and Unstable on Huntington\u2019s Disease Chromosomes. Cell 72: 971\u2013983.","journal-title":"Cell"},{"key":"6_CR10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross, C.A., E.H. Aylward, E.J. Wild, D.R. Langbehn, J.D. Long, J.H. Warner, R.I. Scahill, B.R. Leavitt, J.C. Stout, J.S. Paulsen, R. Reilmann, P.G. Unschuld, A. Wexler, R.L. Margolis, and S.J. Tabrizi. 2014. Huntington Disease: Natural History, Biomarkers and Prospects for Therapeutics. Nature Review Neurology 10: 204\u2013216.","journal-title":"Nature Review Neurology"},{"key":"6_CR11","volume-title":"Huntington's Disease","year":"1996","unstructured":"Harper, P.S., ed. 1996. Huntington's Disease. 2nd ed. London, UK: Saunders Publications.","edition":"2"},{"key":"6_CR12","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/mds.26011","volume":"29","author":"R Reilmann","year":"2014","unstructured":"Reilmann, R., B.R. Leavitt, and C.A. Ross. 2014. Diagnostic Criteria for Huntington\u2019s Disease Based on Natural History. Movement Disorders 29: 1335\u20131341.","journal-title":"Movement Disorders"},{"key":"6_CR13","doi-asserted-by":"crossref","first-page":"c3109","DOI":"10.1136\/bmj.c3109","volume":"340","author":"MJ Novak","year":"2010","unstructured":"Novak, M.J., and S.J. Tabrizi. 2010. Huntington\u2019s Disease. British Medical Journal 340: c3109.","journal-title":"British Medical Journal"},{"key":"6_CR14","volume-title":"A Physician\u2019s Guide to the Management of Huntington\u2019s Disease","author":"M Nance","year":"2011","unstructured":"Nance, M., J.S. Paulsen, A. Rosenblatt, and V. Wheelock. 2011. A Physician\u2019s Guide to the Management of Huntington\u2019s Disease. 3rd ed. USA: Huntington\u2019s Disease Society of America.","edition":"3"},{"issue":"8545","key":"6_CR15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(87)90541-1","volume":"1","author":"OW Quarrell","year":"1987","unstructured":"Quarrell, O.W., A.L. Meredith, A. Tyler, S. Youngman, M. Upadhyaya, and P.S. Harper. 1987. Exclusion Testing for Huntington\u2019s Disease in Pregnancy with a Closely Linked DNA Marker. Lancet 1 (8545): 1281\u20131283.","journal-title":"Lancet"},{"issue":"8545","key":"6_CR16","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0140-6736(87)90542-3","volume":"1","author":"MR Hayden","year":"1987","unstructured":"Hayden, M.R., J. Hewitt, J.J. Kastelein, S. Langlois, R.D. Wilson, S. Fox, C. Hilbert, and M. Bloch. 1987. First-Trimester Prenatal Diagnosis for Huntington\u2019s Disease with DNA Probes. Lancet 1 (8545): 1284\u20131285.","journal-title":"Lancet"},{"key":"6_CR17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jmg.25.9.577","volume":"25","author":"LA Farrer","year":"1988","unstructured":"Farrer, L.A., R.H. Myers, L.A. Cupples, and P.M. Conneally. 1988. Considerations in Using Linkage Analysis as a Presymptomatic Test for Huntington\u2019s Disease. Journal of Medical Genetics 25: 577\u2013588.","journal-title":"Journal of Medical Genetics"},{"key":"6_CR18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/bmj.300.6732.1089","volume":"300","author":"PS Harper","year":"1990","unstructured":"Harper, P.S., M.J. Morris, and A. Tyler. 1990. Genetic Testing for Huntington\u2019s Disease. British Medical Journal 300: 1089\u20131090.","journal-title":"British Medical Journal"},{"key":"6_CR19","unstructured":"Yapijakis C. Molecular Genetic Study of Huntington\u2019s Chorea and Myotonic Dystrophy in Greek Families. Doctorate Dissertation Thesis, Department of Biology, University of Athens, 1993."},{"key":"6_CR20","volume-title":"Prenatal Testing for Late Onset Neurogenetic Diseases","author":"C Yapijakis","year":"2002","unstructured":"Yapijakis, C., F. Laccone, and S.A. Sorensen. 2002. Predictive and Prenatal Testing for Huntington\u2019s Disease in Greece, Germany, Austria, Switzerland and Denmark. In Prenatal Testing for Late Onset Neurogenetic Diseases, ed. G. Evers-Kiebooms, M. Zoeteweij, and P.S. Harper. Oxford, UK: BIOS Scientific Publishers."},{"key":"6_CR21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000472303","volume":"3","author":"C Yapijakis","year":"1995","unstructured":"Yapijakis, C., D. Vassilopoulos, M. Tzagournisakis, T. Maris, C. Fesdjian, C. Papageorgiou, and A. Plaitakis. 1995. Linkage Disequilibrium Between the Expanded (CAG)n Repeat and an Allele of the Adjacent (CCG)n Repeat in Huntington\u2019s Disease Patients of Greek Origin. European Journal of Human Genetics 3: 228\u2013234.","journal-title":"European Journal of Human Genetics"},{"key":"6_CR22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00109-013-1016-2","volume":"91","author":"A Fiszer","year":"2013","unstructured":"Fiszer, A., and W.J. Krzyzosiak. 2013. RNA Toxicity in Polyglutamine Disorders: Concepts, Models, and Progress of Research. Journal of Molecular Medicine 91: 683\u2013691.","journal-title":"Journal of Molecular Medicine"},{"key":"6_CR23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.ejhg.5200781","volume":"10","author":"G \u0395vers-Kiebooms","year":"2002","unstructured":"\u0395vers-Kiebooms, G., K. Nys, P. Harper, M. Zoeteweij, A. Durr, G. Jacopini, C. Yapijakis, and S. Simpson. 2002. Predictive DNA Testing for Huntington\u2019s Disease and Reproductive Decision Making: A European Collaborative Study. European Journal of Human Genetics 10: 167\u2013176.","journal-title":"European Journal of Human Genetics"},{"key":"6_CR24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.ejhg.5200871","volume":"10","author":"S Simpson","year":"2002","unstructured":"Simpson, S., M. Zoeteweij, K. Nys, P. Harper, A. Durr, G. Jacopini, C. Yapijakis, and G. Evers-Kiebooms. 2002. Prenatal Testing for Huntington\u2019s Disease: A European Collaborative Study. European Journal of Human Genetics 10: 689\u2013693.","journal-title":"European Journal of Human Genetics"},{"key":"6_CR25","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1212\/WNL.44.8.1533","volume":"44","author":"International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington\u2019s Chorea","year":"1994","unstructured":"International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington\u2019s Chorea. 1994. Guidelines for the Molecular Genetics Predictive test in Huntington\u2019s Disease. Neurology 44: 1533\u20131536.","journal-title":"Neurology"},{"key":"6_CR26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1399-0004.2012.01900.x","volume":"83","author":"R MacLeod","year":"2013","unstructured":"MacLeod, R., A. Tibben, M. Frontali, G. Evers-Kiebooms, A. Jones, A. Martinez-Descales, and R.A. Roos. 2013. Editorial Committee and Working Group \u2018Genetic Testing Counselling\u2019 of the European Huntington Disease Network. Recommendations for the Predictive Genetic Test in Huntington\u2019s Disease. Clinical Genetics 83: 221\u2013231.","journal-title":"Clinical Genetics"},{"key":"6_CR27","doi-asserted-by":"crossref","DOI":"10.4324\/9780203450291","volume-title":"Prenatal Testing for Late Onset Neurogenetic Diseases","author":"G Evers-Kiebooms","year":"2002","unstructured":"Evers-Kiebooms, G., and M. Zoeteweij. 2002. In Prenatal Testing for Late Onset Neurogenetic Diseases, ed. P.S. Harper. Oxford, UK: BIOS."},{"key":"6_CR28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker, F.O. 2007. Huntington\u2019s Disease. Lancet 369: 218\u2013228.","journal-title":"Lancet"},{"key":"6_CR29","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/ejhg.2016.59","volume":"24","author":"H Bouchghoul","year":"2016","unstructured":"Bouchghoul, H., S.F. Cl\u00e9ment, D. Vauthier, C. Cazeneuve, S. Noel, M. Dommergues, D. H\u00e9ron, J. Nizard, M. Gargiulo, and A. Durr. 2016. Prenatal Testing in Huntington Disease: After the Test, Choices Recommence. European Journal of Human Genetics 24: 1535\u20131540.","journal-title":"European Journal of Human Genetics"},{"key":"6_CR30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13023-014-0114-8","volume":"9","author":"T Vinther-Jensen","year":"2014","unstructured":"Vinther-Jensen, T., I.U. Larsen, L.E. Hjermind, E. Budtz-J\u00f8rgensen, T.T. Nielsen, A. N\u00f8rrem\u00f8lle, J.E. Nielsen, and A. Vogel. 2014. A Clinical Classification Acknowledging Neuropsychiatric and Cognitive Impairment in Huntington\u2019s Disease. Orphanet Journal of Rare Diseases 9: 114.","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"6_CR31","doi-asserted-by":"crossref","first-page":"RRN1283","DOI":"10.1371\/currents.RRN1283","volume":"3","author":"R Dorsey","year":"2011","unstructured":"Dorsey, R., K. Biglan, S. Eberly, P. Auinger, A. Brocht, C.C. Umeh, D. Oakes, K. Clarence-Smith, F. Marshall, I. Shoulson, and S. Frank. 2011. Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study. PLoS Curr 3: RRN1283.","journal-title":"PLoS Curr"},{"key":"6_CR32","unstructured":"www.huntington-study-group.org\/ClinicalResearch\/ ."},{"key":"6_CR33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi, S.J., R.I. Scahill, G. Owen, A. Durr, B.R. Leavitt, R.A. Roos, B. Borowsky, B. Landwehrmeyer, C. Frost, H. Johnson, D. Craufurd, R. Reilmann, J.C. Stout, and D.R. Langbehn. 2013. TRACK-HD Investigators. Predictors of Phenotypic Progression and Disease Onset in Premanifest and Early-Stage Huntington\u2019s Disease in the TRACK-HD Study: Analysis of 36-Month Observational Data. Lancet Neurology 12: 637\u2013649.","journal-title":"Lancet Neurology"},{"key":"6_CR34","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/mds.25964","volume":"29","author":"JC Stout","year":"2014","unstructured":"Stout, J.C., S. Queller, K.N. Baker, S. Cowlishaw, C. Sampaio, C. Fitzer-Attas, B. Borowsky, and HD-CAB Investigators. 2014. HD-CAB: A Cognitive Assessment Battery for Clinical Trials in Huntington\u2019s Disease 1,2,3. Movement Disorders 29: 1281\u20131288.","journal-title":"Movement Disorders"},{"key":"6_CR35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4329\/wjr.v6.i6.301","volume":"6","author":"F Niccolini","year":"2014","unstructured":"Niccolini, F., and M. Politis. 2014. Neuroimaging in Huntington\u2019s Disease. World Journal of Radiology 6: 301\u2013312.","journal-title":"World Journal of Radiology"},{"key":"6_CR36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/WCO.0b013e3283489711","volume":"24","author":"K Cheng","year":"2011","unstructured":"Cheng, K. 2011. Recent Progress in High-Resolution Functional MRI. Current Opinion in Neurology 24: 401\u2013408.","journal-title":"Current Opinion in Neurology"},{"key":"6_CR37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jnnp.2007.142786","volume":"81","author":"A Sritharan","year":"2010","unstructured":"Sritharan, A., G.F. Egan, L. Johnston, M. Horne, J.L. Bradshaw, I. Bohanna, H. Asadi, R. Cunnington, A.J. Churchyard, P. Chua, M. Farrow, and N. Georgiou-Karistianis. 2010. A Longitudinal Diffusion Tensor Imaging Study in Symptomatic Huntington\u2019s Disease. Journal of Neurology Neurosurgery and Psychiatry 81: 257\u2013262.","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"6_CR38","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3174\/ajnr.A1891","volume":"31","author":"ML Mandelli","year":"2010","unstructured":"Mandelli, M.L., M. Savoiardo, L. Minati, C. Mariotti, D. Aquino, A. Erbetta, S. Genitrini, S. Di Donato, M.G. Bruzzone, and M. Grisoli. 2010. Decreased Diffusivity in the Caudate Nucleus of Presymptomatic Huntington Disease Gene Carriers: Which Explanation? American Journal of Neuroradiology 31: 706\u2013710.","journal-title":"American Journal of Neuroradiology"},{"key":"6_CR39","doi-asserted-by":"crossref","unstructured":"Plerou A, Bobori C, Vlamos P. Molecular Basis of Huntington\u2019s Disease and Brain Imaging Evidence. The 15th IEEE International Symposium on Signal Processing and Information Technology, Abu Dhabi, December 2015. doi:10.1109\/ISSPIT.2015.7394365.","DOI":"10.1109\/ISSPIT.2015.7394365"},{"key":"6_CR40","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI45130","volume":"121","author":"DW Sah","year":"2011","unstructured":"Sah, D.W., and N. Aronin. 2011. Oligonucleotide Therapeutic Approaches for Huntington Disease. The Journal of Clinical Investigation 121: 500\u2013507.","journal-title":"The Journal of Clinical Investigation"}],"container-title":["Advances in Experimental Medicine and Biology","GeNeDis 2016"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-57379-3_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T23:02:28Z","timestamp":1570143748000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-57379-3_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319573786","9783319573793"],"references-count":40,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-57379-3_6","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}